Health
A molecular trap against COVID-19 – Science Magazine
The cell surface peptidase angiotensin-converting enzyme 2 (ACE2) is the primary receptor for the spike (S) fusion protein that facilitates cell entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Numerous studies are evaluating therapeutic…
The cell surface peptidase angiotensin-converting enzyme 2 (ACE2) is the primary receptor for the spike (S) fusion protein that facilitates cell entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Numerous studies are evaluating therapeutic and preventive treatments that block S protein interactions with ACE2 molecules that are expressed on host cells. For example, the ACE2 binding site can be occluded by monoclonal antibodies, several of which are rapidly advancing in clinica…
-
General23 hours agoMan dies in light plane crash north of Balranald in south-west NSW
-
General22 hours agoWhitewash at QUT | The Spectator Australia
-
Noosa News11 hours agoMore than $25m in workers’ compensation claims relating to e-scooter and e-bike injuries made in Queensland over five-year period
-
Noosa News24 hours agoTargeted attack in Torquay leaves man with gunshot wound to abdomen